Charlene Liao

Outlook Microsoft Office 365 Google Font API Mobile Friendly Squarespace ECommerce Typekit Circle Remote AI

biotechnology research immunotherapy myeloid cells novel therapies blood cancers autoimmune diseases solid tumors lilrb4 lilrb2 ilt3 ilt4 clinical trials fda approval therapeutic antibodies cancer treatment drug development immune modulation innate immune system checkpoint inhibitors novel antibodies bispecific monoclonal antibodies targeted therapies oncology research clinical-stage biopharmaceuticals immune checkpoint immune evasion immune regulation disease pathogenesis translational medicine cancer immunotherapy hematologic malignancies anti-pd-1 t-cell activation tumor microenvironment orphan drug designation fast track designation azacitidine chronic myelomonocytic leukemia acute myeloid leukemia immune suppression drug discovery scientific collaborations peer-reviewed research promising efficacy safety profile therapeutic indices patient access policy biopharmaceutical partnerships regulatory assessment clinical benefit patient-centric approach health care health wellness & fitness hospital & health care